Sweden· SE-20050924000017
Savene 20 mg/ml Pulver till koncentrat och vätska till infusionsvätska, lösning
A medicinal product containing dexrazoxane, registered in Sweden by CNX Therapeutics Ireland Ltd.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Dexrazoxane
- Manufacturer
- CNX Therapeutics Ireland Ltd
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20050924000017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexrazoxane in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandSaveneOrifarm Oy
- PolandCyrdanaxPharmaselect International Beteiligungs GmbH
- BelgiumSavene 20 mg/mlCnx Therapeutics Ireland
- IcelandSaveneCNX Therapeutics Ireland Limited
- NorwaySaveneCNX Therapeutics Ireland Ltd.
- IrelandSavene 20 mg/ml powder and solvent for concentrate for solution for infusionCNX Therapeutics Ireland Limited
- SpainSAVENE 20 mg/ml POLVO PARA CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONCnx Therapeutics Ireland Limited
- United StatesDexrazoxaneFosun Pharma USA Inc.
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Cyrdanax
- Czechia · Cyrdanax
- Germany · Cardioxane, Cyrdanax
- Spain · Cardioxane
- France · Cardioxane, Cyrdanax
- United Kingdom (Northern Ireland) · Cardioxane
- Hungary · Cyrdanax
- Iceland · Savene
- Italy · Cardioxane
- Liechtenstein · Savene
- Netherlands · Cardioxane
- Norway · Savene
- Poland · Cyrdanax
- Romania · Cyrdanax
- Slovakia · Cyrdanax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f7c7060-400a-4632-bcb4-b6d767e067d3 GET /v1/drugs/6f7c7060-400a-4632-bcb4-b6d767e067d3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20050924000017",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050924000017",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/savene"
}See everything about dexrazoxane.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.